PHAT (PHAT) Stock Price & Analysis
PHAT (PHAT) rose 0.00% to USD 11.44 as of July 25, 2026 at 02:23 UTC, according to Nexqual real-time market data.
PHAT last closed at USD 11.44; the session ranged USD 11.34–11.7 on volume of 920,820 shares. Market capitalization is —, with a 52-week range of USD 8.03–18.31 (NMS). Source: Nexqual, July 25, 2026 at 02:23 UTC.
Key Statistics (as of July 25, 2026 at 02:23 UTC)
| Price | USD 11.44 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 11.44 |
| Open | USD 11.44 |
| Day Range | USD 11.34 – 11.7 |
| 52-Week Range | USD 8.03 – 18.31 |
| Volume | 920,820 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (PHAT)
Nexqual's technical model rates PHAT "STRONG BUY" based on 5 bullish and 0 bearish signals across 125 daily candles, as of July 25, 2026 at 02:23 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 55.19 (neutral) |
| vs SMA50 | Above (USD 10.94) |
| MACD | 0.13 (positive) |
From PHAT's Latest SEC 10-K Filing (filed 2026-02-26)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| STOK | Stoke Therapeutics, Inc. | USD 29.3 | ▲ 1.17% |
| ORIC | Oric Pharmaceuticals, Inc. | USD 12.1 | ▲ 12.56% |
| MIRM | Mirum Pharmaceuticals, Inc. | USD 113.03 | ▼ 1.27% |
| TARS | Tarsus Pharmaceuticals, Inc. | USD 58.66 | ▲ 1.88% |
| ARQT | Arcutis Biotherapeutics, Inc. | USD 27.35 | ▼ 1.97% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 02:23 UTC. This page is informational and not investment advice.